Device Trial Radar · NCT07688720
Transcutaneous Auricular Neurostimulation (tAN) for Premenstrual Dysphoric Disorder (PMDD) and Perimenopause
Last checked: Nov 19, 2026Latest source record: Oct 23, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Enrolling by invitation
Enrollment
20
Planned (sponsor's estimate)
Start
Oct 22, 2026
Primary completion
Mar 2028
Study completion Jun 2028
Sponsor
- Lead sponsor
- Texas Christian UniversityAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Spark Biomedical, Inc.
- First posted
- Jul 7, 2026
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- Female only, from 18 years, up to 55 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Transcutaneous Auricular Neurostimulation (tAN) will be administered to women with premenstrual syndrome (PMS), premenstrual dysphoric disorder (PMDD), and perimenopause. The investigators will examine whether tAN improves symptomology by collecting self-report data before the intervention, during the intervention, and following the intervention.
Conditions
- Perimenopause
- PMDD
Interventions
transcutaneous auricular neurostimulation (tAN)Device
Device: Sparrow Link. The Sparrow Link will be using the components of the Sparrow Ascent device: (FDA-cleared K230796) a wearable, battery-operated, neurostimulation system designed to transcutaneously stimulate nerves on and/or around the auricle. This device will stimulate the auriculotemporal nerve (ATN) and the auricular branch of the vagus nerve (ABVN)
Primary outcomes
What the sponsor says the trial is designed to measure.
- Daily Record of Severity of Problems (DRSP)Time frame: Assessed daily from study initiation until the end of the study, an average of four months (4 cycles). Menstrual cycle length varies but is generally 21-35 days.
- Green Climacteric ScaleTime frame: Participants will complete this measure monthly from study initiation until the end of the study, about three months.
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Texas Christian University
Fort Worth, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.